Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats (Q43631917)

25 November 2017

Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats (English)

1 reference

25 November 2017

0 references

1 reference

Letechipía-Vallejo G

1

1 reference

PubMed ID

11395182

25 November 2017

González-Burgos I

series ordinal

2

1 reference

PubMed ID

11395182

25 November 2017

Cervantes M

series ordinal

3

1 reference

25 November 2017

1 May 2001

1 reference

Archives of Medical Research

25 November 2017

1 reference

25 November 2017

32

1 reference

25 November 2017

3

1 reference

25 November 2017

186-192

1 reference

Global brain ischemia and reperfusion

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Mechanisms of ischemic cerebral injury

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Brain cell death following ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Pattern of neuronal vulnerability in the cat hippocampus after one hour of global cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Selective vulnerability of the hippocampus in brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Free radical generation during brief period of cerebral ischemia may trigger delayed neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Oxygen radical mechanisms of brain injury following ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Role of oxidants in ischemic brain damage

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective effects of pterin-6-aldehyde in gerbil global brain ischemia: comparison with those of alpha-phenyl-N-tert-butyl nitrone.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Melatonin reduces H2O2-induced lipid peroxidation in homogenates of different rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Significance of melatonin in antioxidative defense system: reactions and products

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

In vitro and in vivo protective effects of melatonin against glutamate oxidative stress and neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective action of the pineal hormone melatonin against excitotoxicity. Receptor abuse-dependent antagonism (RADA).

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Prophylactic actions of melatonin in oxidative neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Melatonin administration protects CA1 hippocampal neurons after transient forebrain ischemia in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Pinealectomy aggravates and melatonin administration attenuates brain damage in focal ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Melatonin stimulates brain glutathione peroxidase activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

The neurologic effects of thiopental therapy following experimental cardiac arrest in cats.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Identity of the dorsal hippocampal region most vulnerable to cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Effects of an A1 adenosine receptor agonist on the neurochemical, behavioral and histological consequences of ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

The antioxidant LY231617 reduces global ischemic neuronal injury in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective activity of the potent and selective mGlu1a metabotropic glutamate receptor antagonist, (+)-2-methyl-4 carboxyphenylglycine (LY367385): comparison with LY357366, a broader spectrum antagonist with equal affinity for mGlu1a and mGlu5 r

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

LY379268, a potent and selective Group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

alpha-Phenyl-tert-butyl-nitrone (PBN) attenuates hydroxyl radical production during ischemia-reperfusion injury of rat brain: an EPR study.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Neuroprotective efficacy and mechanisms of novel pyrrolopyrimidine lipid peroxidation inhibitors in the gerbil forebrain ischemia model.

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0188-4409%2801%2900268-5

7 January 2021

10.1016/S0188-4409(01)00268-5

Identifiers

DOI

1 reference

25 November 2017

1 reference

PubMed ID

11395182